80.00
0.50 (0.63%)
| Penutupan Terdahulu | 79.50 |
| Buka | 79.95 |
| Jumlah Dagangan | 39,800 |
| Purata Dagangan (3B) | 534,362 |
| Modal Pasaran | 36,636,745,728 |
| Harga / Pendapatan (P/E TTM) | 25.48 |
| Harga / Jualan (P/S) | 4.01 |
| Harga / Buku (P/B) | 1.44 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 25 Apr 2025 - 28 Apr 2025 |
| Hasil Dividen (DY TTM) | 1.17% |
| Margin Keuntungan | 16.71% |
| Margin Operasi (TTM) | 19.57% |
| EPS Cair (TTM) | 3.08 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 10.10% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 15.80% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 1.85% |
| Nisbah Semasa (MRQ) | 7.16 |
| Aliran Tunai Operasi (OCF TTM) | 1.21 B |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -481.74 M |
| Pulangan Atas Aset (ROA TTM) | 2.29% |
| Pulangan Atas Ekuiti (ROE TTM) | 5.64% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (HK) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | ASYMCHEM | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -2.0 |
| Purata | -0.38 |
Saham Serupa
| Stok | Modal Pasaran | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| ASYMCHEM | 37 B | 1.17% | 25.48 | 1.44 |
| REMEGEN | 55 B | - | - | 19.48 |
| ZAI LAB | 17 B | - | - | 2.92 |
| HBM HOLDINGS-B | 11 B | - | 18.47 | 5.17 |
| AKESO | 111 B | - | - | 15.36 |
| PHARMARON | 56 B | 0.92% | 22.04 | 2.39 |
|
Asymchem Laboratories Tianjin Co Ltd is a China-based company, a technology-driven provider of Contract Development manufacturing organization solutions throughout the drug development and manufacturing process. The Group provides clinical-stage CDMO solutions, commercial-stage CDMO solutions, and emerging services. Its operations relate to contract development and manufacturing which focuses on innovation and commercial application of pharmaceutical technology. It has geographic areas in the Chinese Mainland and Overseas. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Mid Core |
| % Dimiliki oleh Institusi | 52.92% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |